262 related articles for article (PubMed ID: 38346978)
1. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.
Licaj M; Mhaidly R; Kieffer Y; Croizer H; Bonneau C; Meng A; Djerroudi L; Mujangi-Ebeka K; Hocine HR; Bourachot B; Magagna I; Leclere R; Guyonnet L; Bohec M; Guérin C; Baulande S; Kamal M; Le Tourneau C; Lecuru F; Becette V; Rouzier R; Vincent-Salomon A; Gentric G; Mechta-Grigoriou F
Nat Commun; 2024 Feb; 15(1):1312. PubMed ID: 38346978
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer.
Kieffer Y; Hocine HR; Gentric G; Pelon F; Bernard C; Bourachot B; Lameiras S; Albergante L; Bonneau C; Guyard A; Tarte K; Zinovyev A; Baulande S; Zalcman G; Vincent-Salomon A; Mechta-Grigoriou F
Cancer Discov; 2020 Sep; 10(9):1330-1351. PubMed ID: 32434947
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer.
Croizer H; Mhaidly R; Kieffer Y; Gentric G; Djerroudi L; Leclere R; Pelon F; Robley C; Bohec M; Meng A; Meseure D; Romano E; Baulande S; Peltier A; Vincent-Salomon A; Mechta-Grigoriou F
Nat Commun; 2024 Apr; 15(1):2806. PubMed ID: 38561380
[TBL] [Abstract][Full Text] [Related]
4. miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.
Givel AM; Kieffer Y; Scholer-Dahirel A; Sirven P; Cardon M; Pelon F; Magagna I; Gentric G; Costa A; Bonneau C; Mieulet V; Vincent-Salomon A; Mechta-Grigoriou F
Nat Commun; 2018 Mar; 9(1):1056. PubMed ID: 29535360
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblast spatial heterogeneity and
Honda CK; Kurozumi S; Fujii T; Pourquier D; Khellaf L; Boissiere F; Horiguchi J; Oyama T; Shirabe K; Colinge J; Yokobori T; Turtoi A
Theranostics; 2024; 14(5):1873-1885. PubMed ID: 38505604
[No Abstract] [Full Text] [Related]
6. CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer.
Wessolly M; Mairinger E; Borchert S; Bankfalvi A; Mach P; Schmid KW; Kimmig R; Buderath P; Mairinger FD
Front Oncol; 2022; 12():798680. PubMed ID: 35311102
[TBL] [Abstract][Full Text] [Related]
7. Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
Li B; Pei G; Yao J; Ding Q; Jia P; Zhao Z
Oncogene; 2021 Jul; 40(28):4686-4694. PubMed ID: 34140640
[TBL] [Abstract][Full Text] [Related]
8. Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.
Hussain A; Voisin V; Poon S; Karamboulas C; Bui NHB; Meens J; Dmytryshyn J; Ho VW; Tang KH; Paterson J; Clarke BA; Bernardini MQ; Bader GD; Neel BG; Ailles LE
J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32434219
[TBL] [Abstract][Full Text] [Related]
9. FAP
Sun L; Ke M; Wang X; Yin M; Wei J; Xu L; Tian X; Wang F; Zhang H; Fu S; Zhang C
Mol Carcinog; 2022 Oct; 61(10):910-923. PubMed ID: 35801406
[TBL] [Abstract][Full Text] [Related]
10. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma.
Li Y; Tian R; Liu J; Li J; Tan H; Wu Q; Fu X
Front Immunol; 2022; 13():940801. PubMed ID: 36119108
[TBL] [Abstract][Full Text] [Related]
12. Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian Cancer.
Loret N; Vandamme N; De Coninck J; Taminau J; De Clercq K; Blancke G; Jonckheere S; Goossens S; Lemeire K; De Prijck S; Verstaen K; Seurinck R; Van Dorpe J; Weyers S; Denys H; Van de Vijver K; Lambrecht BN; Tummers P; Saeys Y; Berx G
Mol Cancer Res; 2022 Oct; 20(10):1532-1547. PubMed ID: 35749080
[TBL] [Abstract][Full Text] [Related]
13. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
14. A miRNA-145/TGF-β1 negative feedback loop regulates the cancer-associated fibroblast phenotype.
Melling GE; Flannery SE; Abidin SA; Clemmens H; Prajapati P; Hinsley EE; Hunt S; Catto JWF; Coletta RD; Mellone M; Thomas GJ; Parkinson EK; Prime SS; Paterson IC; Buttle DJ; Lambert DW
Carcinogenesis; 2018 May; 39(6):798-807. PubMed ID: 29506142
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
16. [Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer].
Zhang YN; Li B; Li YQ; Liu SH; Hou HY; Wang KY; Ao M; Song Y
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):368-377. PubMed ID: 37217344
[No Abstract] [Full Text] [Related]
17. Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis.
Mellone M; Hanley CJ; Thirdborough S; Mellows T; Garcia E; Woo J; Tod J; Frampton S; Jenei V; Moutasim KA; Kabir TD; Brennan PA; Venturi G; Ford K; Herranz N; Lim KP; Clarke J; Lambert DW; Prime SS; Underwood TJ; Vijayanand P; Eliceiri KW; Woelk C; King EV; Gil J; Ottensmeier CH; Thomas GJ
Aging (Albany NY); 2016 Dec; 9(1):114-132. PubMed ID: 27992856
[TBL] [Abstract][Full Text] [Related]
18. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
[TBL] [Abstract][Full Text] [Related]
19. The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy.
van Baal JOAM; Lok CAR; Jordanova ES; Horlings H; van Driel WJ; Amant FC; Van de Vijver KK
Virchows Arch; 2020 Oct; 477(4):535-544. PubMed ID: 32179982
[TBL] [Abstract][Full Text] [Related]
20. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
Wu YH; Huang YF; Chang TH; Chen CC; Wu PY; Huang SC; Chou CY
Oncogene; 2021 Jul; 40(26):4503-4519. PubMed ID: 34117361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
